(+)-epicatechin-3-O-gallate multiple interactions ISO RGD:10730 6480464 epicatechin gallate inhibits the reaction [Benzo(a)pyrene results in increased expression of HRAS mRNA], epicatechin gallate inhibits the reaction [Benzo(a)pyrene results in increased expression of HRAS protein] CTD PMID:18656336 (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:10730 6480464 epigallocatechin gallate inhibits the reaction [Benzo(a)pyrene results in increased expression of HRAS mRNA], epigallocatechin gallate inhibits the reaction [Benzo(a)pyrene results in increased expression of HRAS protein] CTD PMID:18656336 (S)-nicotine multiple interactions ISO RGD:10730 6480464 [Nicotine co-treated with 1-Methyl-4-phenyl-1 more ... CTD PMID:20230807 (S)-nicotine increases activity EXP 6480464 Nicotine results in increased activity of HRAS protein CTD PMID:15983034 1,2-dichlorobenzene increases expression EXP 6480464 2-dichlorobenzene results in increased expression of HRAS mRNA CTD PMID:10614693 1,2-dichloroethane increases response to substance ISO RGD:10730 6480464 HRAS protein results in increased susceptibility to ethylene dichloride CTD PMID:28421967 1,2-dichloroethane increases expression ISO RGD:10730 6480464 ethylene dichloride results in increased expression of HRAS mRNA CTD PMID:28960355 1,2-dimethylhydrazine increases expression ISO RGD:10730 6480464 1, 2-Dimethylhydrazine results in increased expression of HRAS mRNA CTD PMID:22206623 1,2-dimethylhydrazine multiple interactions ISO RGD:10730 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of HRAS mRNA CTD PMID:22206623 1-Amino-2,4-dibromoanthraquinone increases mutagenesis ISO RGD:10730 6480464 1-amino-2, 4-dibromoanthraquinone results in increased mutagenesis of HRAS gene CTD PMID:11560247 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine multiple interactions ISO RGD:10730 6480464 [Caffeine co-treated with 1-Methyl-4-phenyl-1 more ... CTD PMID:20230807 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine decreases expression ISO RGD:10730 6480464 1-Methyl-4-phenyl-1 more ... CTD PMID:20230807 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of HRAS mRNA CTD PMID:20551477 1-nitropyrene affects expression EXP 6480464 1-nitropyrene affects the expression of HRAS mRNA CTD PMID:11201684 1-nitropyrene increases expression ISO RGD:10730 6480464 1-nitropyrene results in increased expression of HRAS mRNA CTD PMID:11911274 , PMID:9891514 17alpha-ethynylestradiol increases expression ISO RGD:10730 6480464 Ethinyl Estradiol results in increased expression of HRAS mRNA CTD PMID:17942748 17alpha-ethynylestradiol multiple interactions ISO RGD:10730 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of HRAS mRNA CTD PMID:17942748 17beta-estradiol affects expression ISO RGD:730881 6480464 Estradiol affects the expression of HRAS mRNA CTD PMID:21826169 17beta-estradiol increases expression ISO RGD:730881 6480464 Estradiol results in increased expression of HRAS mRNA CTD PMID:16051634 , PMID:23094148 17beta-estradiol increases expression ISO RGD:10730 6480464 Estradiol results in increased expression of HRAS mRNA CTD PMID:22467019 17beta-estradiol multiple interactions ISO RGD:730881 6480464 dibenzoylmethane inhibits the reaction [Estradiol results in increased expression of HRAS mRNA] more ... CTD PMID:12117780 , PMID:16051634 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:10730 6480464 Tetrachlorodibenzodioxin results in decreased expression of HRAS mRNA CTD PMID:21354282 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of HRAS mRNA CTD PMID:33387578 , PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:10730 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of HRAS mRNA CTD PMID:17942748 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of HRAS mRNA CTD PMID:21346803 2,6-di-tert-butyl-4-methylphenol decreases methylation EXP 6480464 Butylated Hydroxytoluene results in decreased methylation of HRAS gene CTD PMID:9780227 2,6-di-tert-butyl-4-methylphenol increases response to substance ISO RGD:10730 6480464 HRAS protein results in increased susceptibility to Butylated Hydroxytoluene CTD PMID:11599794 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of HRAS mRNA CTD PMID:21346803 2-acetamidofluorene increases expression EXP 6480464 2-Acetylaminofluorene results in increased expression of HRAS protein CTD PMID:11350689 2-trans,6-trans,10-trans-geranylgeranyl diphosphate multiple interactions ISO RGD:730881 6480464 geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [Lipopolysaccharides results in increased activity of HRAS protein]] CTD PMID:18625914 2-trans,6-trans-farnesyl diphosphate multiple interactions ISO RGD:730881 6480464 farnesyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [Lipopolysaccharides results in increased activity of HRAS protein]], farnesyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [Lipopolysaccharides results in increased localization of HRAS protein]] CTD PMID:18625914 3-aminobenzamide multiple interactions ISO RGD:730881 6480464 3-aminobenzamide inhibits the reaction [hydroquinone results in increased expression of HRAS protein] CTD PMID:26047893 3-methyl-3H-imidazo[4,5-f]quinolin-2-amine increases mutagenesis EXP 6480464 2-amino-3-methylimidazo(4, 5-f)quinoline results in increased mutagenesis of HRAS gene CTD PMID:2009133 , PMID:8844820 4,4'-sulfonyldiphenol affects methylation ISO RGD:10730 6480464 bis(4-hydroxyphenyl)sulfone affects the methylation of HRAS gene CTD PMID:31683443 4-hydroperoxycyclophosphamide decreases expression ISO RGD:10730 6480464 perfosfamide results in decreased expression of HRAS mRNA CTD PMID:19429390 4-hydroxyphenyl retinamide decreases expression ISO RGD:10730 6480464 Fenretinide results in decreased expression of HRAS mRNA CTD PMID:16467112 4-nitrophenol affects glucuronidation ISO RGD:730881 6480464 HRAS protein affects the glucuronidation of 4-nitrophenol CTD PMID:11695553 4-nitroquinoline N-oxide multiple interactions ISO RGD:730881 6480464 [4-Nitroquinoline-1-oxide co-treated with HRAS] results in increased expression of CCND1 mRNA more ... CTD PMID:20043093 4-octylphenol multiple interactions ISO RGD:730881 6480464 4-octylphenol affects the reaction [HRAS protein results in increased susceptibility to 9 more ... CTD PMID:12117780 5-aza-2'-deoxycytidine decreases expression ISO RGD:730881 6480464 Decitabine results in decreased expression of HRAS mRNA CTD PMID:19027819 5-fluorouracil increases expression ISO RGD:730881 6480464 Fluorouracil results in increased expression of HRAS mRNA CTD PMID:16557594 7,12-dimethyltetraphene multiple interactions ISO RGD:730881 6480464 4-octylphenol affects the reaction [HRAS protein results in increased susceptibility to 9 more ... CTD PMID:12117780 7,12-dimethyltetraphene increases mutagenesis ISO RGD:10730 6480464 9 more ... CTD PMID:1375869 , PMID:20103723 7,12-dimethyltetraphene multiple interactions ISO RGD:10730 6480464 [9 more ... CTD PMID:11241758 more ... 7,12-dimethyltetraphene increases response to substance ISO RGD:730881 6480464 HRAS protein results in increased susceptibility to 9 more ... CTD PMID:11376698 , PMID:12117780 8-hydroxy-2'-deoxyguanosine increases abundance ISO RGD:10730 6480464 HRAS protein mutant form results in increased abundance of 8-Hydroxy-2'-Deoxyguanosine CTD PMID:27517622 8-hydroxy-2'-deoxyguanosine multiple interactions ISO RGD:10730 6480464 PRDX1 protein inhibits the reaction [HRAS protein mutant form results in increased abundance of 8-Hydroxy-2'-Deoxyguanosine] CTD PMID:27517622 acrolein multiple interactions ISO RGD:730881 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of HRAS mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of HRAS mRNA CTD PMID:32699268 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of HRAS mRNA CTD PMID:28959563 actinomycin D multiple interactions ISO RGD:730881 6480464 Dactinomycin promotes the reaction [[Zinostatin co-treated with Glutathione] results in increased cleavage of HRAS gene] CTD PMID:9345283 ADP multiple interactions ISO RGD:730881 6480464 Adenosine Diphosphate binds to and affects the folding of HRAS protein CTD PMID:16388579 aflatoxin B1 affects expression ISO RGD:730881 6480464 Aflatoxin B1 affects the expression of HRAS protein CTD PMID:20106945 aflatoxin B1 increases expression ISO RGD:730881 6480464 Aflatoxin B1 results in increased expression of HRAS mRNA CTD PMID:22100608 more ... aflatoxin B1 increases expression ISO RGD:10730 6480464 Aflatoxin B1 results in increased expression of HRAS mRNA CTD PMID:19770486 aldehydo-D-glucose multiple interactions EXP 6480464 manumycin inhibits the reaction [Glucose results in increased activity of HRAS protein] CTD PMID:16572112 aldehydo-D-glucose increases activity EXP 6480464 Glucose results in increased activity of HRAS protein CTD PMID:16572112 alendronic acid decreases prenylation ISO RGD:10730 6480464 Alendronate results in decreased prenylation of HRAS protein CTD PMID:9556058 all-trans-retinoic acid decreases expression ISO RGD:10730 6480464 Tretinoin results in decreased expression of HRAS mRNA CTD PMID:16604517 alpha-pinene multiple interactions ISO RGD:730881 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of HRAS mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of HRAS mRNA CTD PMID:32699268 aristolochic acid A increases mutagenesis EXP 6480464 aristolochic acid I results in increased mutagenesis of HRAS gene CTD PMID:21642617 aristolochic acid A increases expression ISO RGD:730881 6480464 aristolochic acid I results in increased expression of HRAS mRNA CTD PMID:33212167 Aroclor 1254 increases expression EXP 6480464 Chlorodiphenyl (54% Chlorine) results in increased expression of HRAS mRNA CTD PMID:8471063 arsane affects methylation ISO RGD:730881 6480464 Arsenic affects the methylation of HRAS gene CTD PMID:25304211 arsane multiple interactions ISO RGD:10730 6480464 Arsenic inhibits the reaction [[NR3C1 protein binds to HRAS promoter] which results in increased expression of HRAS mRNA] more ... CTD PMID:21784148 arsenic atom affects methylation ISO RGD:730881 6480464 Arsenic affects the methylation of HRAS gene CTD PMID:25304211 arsenic atom multiple interactions ISO RGD:10730 6480464 Arsenic inhibits the reaction [[NR3C1 protein binds to HRAS promoter] which results in increased expression of HRAS mRNA] more ... CTD PMID:21784148 arsenous acid increases expression ISO RGD:730881 6480464 Arsenic Trioxide results in increased expression of HRAS mRNA CTD PMID:29633893 arsenous acid multiple interactions ISO RGD:730881 6480464 [Tetradecanoylphorbol Acetate co-treated with Arsenic Trioxide] results in increased expression of HRAS mRNA CTD PMID:18922899 aspartame increases expression ISO RGD:10730 6480464 Aspartame results in increased expression of HRAS CTD PMID:17354619 atrazine decreases expression ISO RGD:730881 6480464 Atrazine results in decreased expression of HRAS mRNA CTD PMID:22378314 benzene decreases expression ISO RGD:730881 6480464 Benzene results in decreased expression of HRAS mRNA CTD PMID:33064461 benzo[a]pyrene multiple interactions ISO RGD:10730 6480464 [Benzo(a)pyrene co-treated with Tetradecanoylphorbol Acetate] affects the mutagenesis of HRAS gene more ... CTD PMID:11765016 more ... benzo[a]pyrene affects methylation ISO RGD:730881 6480464 Benzo(a)pyrene affects the methylation of HRAS promoter CTD PMID:27901495 benzo[a]pyrene decreases methylation ISO RGD:730881 6480464 Benzo(a)pyrene results in decreased methylation of HRAS 5' UTR CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:10730 6480464 Benzo(a)pyrene results in increased expression of HRAS mRNA, Benzo(a)pyrene results in increased expression of HRAS protein CTD PMID:18656336 , PMID:20504355 benzo[a]pyrene decreases expression ISO RGD:10730 6480464 Benzo(a)pyrene results in decreased expression of HRAS mRNA CTD PMID:22228805 benzo[a]pyrene increases expression ISO RGD:730881 6480464 Benzo(a)pyrene metabolite results in increased expression of HRAS mRNA, Benzo(a)pyrene results in increased expression of HRAS mRNA CTD PMID:11008122 , PMID:21632981 benzo[a]pyrene increases response to substance ISO RGD:730881 6480464 HRAS mRNA results in increased susceptibility to Benzo(a)pyrene CTD PMID:22048643 benzo[a]pyrene multiple interactions EXP 6480464 [Sulfur Dioxide co-treated with Benzo(a)pyrene] results in increased expression of HRAS mRNA more ... CTD PMID:19408242 , PMID:20064080 benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of HRAS mRNA, Benzo(a)pyrene results in increased expression of HRAS protein CTD PMID:19408242 , PMID:20064080 benzo[a]pyrene diol epoxide I increases expression ISO RGD:730881 6480464 7 more ... CTD PMID:18567617 Benzo[a]pyrene-7,8-diol increases expression ISO RGD:730881 6480464 benzo(a)pyrene 7, 8-dihydrodiol results in increased expression of HRAS mRNA CTD PMID:11008122 benzo[c]phenanthrene increases mutagenesis ISO RGD:10730 6480464 benzo(c)phenanthrene analog results in increased mutagenesis of HRAS gene CTD PMID:7955041 Benzoyl peroxide multiple interactions ISO RGD:10730 6480464 [9 more ... CTD PMID:11241758 , PMID:3115617 Benzoyl peroxide increases mutagenesis ISO RGD:10730 6480464 Benzoyl Peroxide results in increased mutagenesis of HRAS gene CTD PMID:11241758 beryllium atom increases mutagenesis EXP 6480464 Beryllium results in increased mutagenesis of HRAS gene CTD PMID:7545909 beryllium dihydride increases mutagenesis EXP 6480464 Beryllium results in increased mutagenesis of HRAS gene CTD PMID:7545909 beryllium(0) increases mutagenesis EXP 6480464 Beryllium results in increased mutagenesis of HRAS gene CTD PMID:7545909 biphenyl-2-ol multiple interactions ISO RGD:730881 6480464 [2-phenylphenol metabolite co-treated with NAD co-treated with Copper] results in increased mutagenesis of HRAS gene more ... CTD PMID:10334203 biphenyl-4-amine increases mutagenesis ISO RGD:10730 6480464 4-biphenylamine results in increased mutagenesis of HRAS gene CTD PMID:15761837 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:10730 6480464 Diethylhexyl Phthalate results in decreased expression of HRAS mRNA CTD PMID:28085963 bisphenol A affects expression ISO RGD:730881 6480464 bisphenol A affects the expression of HRAS mRNA CTD PMID:21826169 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of HRAS mRNA CTD PMID:33296240 bortezomib multiple interactions ISO RGD:10730 6480464 ATG5 gene mutant form inhibits the reaction [HRAS protein promotes the reaction [Bortezomib results in increased cleavage of and results in increased activity of CASP3 protein]], HRAS protein promotes the reaction [Bortezomib results in increased cleavage of and results in increased activity of CASP3 protein] CTD PMID:22842577 buta-1,3-diene increases mutagenesis ISO RGD:10730 6480464 1, 3-butadiene results in increased mutagenesis of HRAS gene CTD PMID:11397402 cadmium dichloride multiple interactions ISO RGD:730881 6480464 HRAS protein mutant form affects the reaction [Cadmium Chloride results in decreased activity of CASP3 protein] CTD PMID:23376331 cadmium dichloride affects expression ISO RGD:730881 6480464 Cadmium Chloride affects the expression of HRAS protein CTD PMID:23376331 cadmium dichloride affects response to substance ISO RGD:730881 6480464 HRAS protein mutant form affects the susceptibility to Cadmium Chloride CTD PMID:23376331 caffeine multiple interactions ISO RGD:10730 6480464 [Caffeine co-treated with 1-Methyl-4-phenyl-1 more ... CTD PMID:20230807 capecitabine decreases response to substance ISO RGD:730881 6480464 HRAS protein results in decreased susceptibility to Capecitabine CTD PMID:16734730 capsaicin increases expression ISO RGD:730881 6480464 Capsaicin results in increased expression of HRAS mRNA CTD PMID:9461043 carbamazepine affects expression ISO RGD:730881 6480464 Carbamazepine affects the expression of HRAS mRNA CTD PMID:24752500 carbon nanotube increases expression ISO RGD:10730 6480464 Nanotubes, Carbon results in increased expression of HRAS mRNA CTD PMID:25554681 chloroprene increases mutagenesis ISO RGD:10730 6480464 Chloroprene results in increased mutagenesis of HRAS gene CTD PMID:11397402 chromium(6+) multiple interactions ISO RGD:10730 6480464 [chromium hexavalent ion co-treated with Benzo(a)pyrene] affects the expression of HRAS mRNA CTD PMID:25820237 chromium(6+) multiple interactions ISO RGD:730881 6480464 HRAS protein promotes the reaction [[sodium bichromate results in increased abundance of chromium hexavalent ion] which results in increased abundance of Hydroxyl Radical] more ... CTD PMID:14971653 ciguatoxin CTX1B affects expression ISO RGD:10730 6480464 Ciguatoxins affects the expression of HRAS mRNA CTD PMID:18353800 cisplatin decreases response to substance ISO RGD:730881 6480464 HRAS results in decreased susceptibility to Cisplatin CTD PMID:21849418 cisplatin multiple interactions ISO RGD:730881 6480464 Cisplatin promotes the reaction [jinfukang results in increased expression of HRAS mRNA], jinfukang promotes the reaction [Cisplatin results in increased expression of HRAS mRNA] CTD PMID:27392435 cisplatin affects splicing ISO RGD:730881 6480464 Cisplatin affects the splicing of HRAS mRNA CTD PMID:23613995 cisplatin increases expression ISO RGD:10730 6480464 Cisplatin results in increased expression of HRAS mRNA CTD PMID:25270620 cisplatin increases expression EXP 6480464 Cisplatin results in increased expression of HRAS mRNA CTD PMID:18172885 copper atom multiple interactions ISO RGD:730881 6480464 [2-phenylphenol metabolite co-treated with NAD co-treated with Copper] results in increased mutagenesis of HRAS gene more ... CTD PMID:10334203 , PMID:11275476 copper(0) multiple interactions ISO RGD:730881 6480464 [2-phenylphenol metabolite co-treated with NAD co-treated with Copper] results in increased mutagenesis of HRAS gene more ... CTD PMID:10334203 , PMID:11275476 copper(II) sulfate decreases expression ISO RGD:730881 6480464 Copper Sulfate results in decreased expression of HRAS mRNA CTD PMID:19549813 crocidolite asbestos decreases expression ISO RGD:730881 6480464 Asbestos, Crocidolite results in decreased expression of HRAS protein CTD PMID:21570478 crocidolite asbestos decreases expression ISO RGD:10730 6480464 Asbestos, Crocidolite results in decreased expression of HRAS mRNA CTD PMID:29279043 cyclosporin A decreases expression ISO RGD:730881 6480464 Cyclosporine results in decreased expression of HRAS mRNA CTD PMID:25562108 D-glucose increases activity EXP 6480464 Glucose results in increased activity of HRAS protein CTD PMID:16572112 D-glucose multiple interactions EXP 6480464 manumycin inhibits the reaction [Glucose results in increased activity of HRAS protein] CTD PMID:16572112 deoxycholic acid increases activity ISO RGD:730881 6480464 Deoxycholic Acid results in increased activity of HRAS protein CTD PMID:18444174 dexamethasone multiple interactions ISO RGD:730881 6480464 Dexamethasone inhibits the reaction [EGF protein promotes the reaction [EGFR protein binds to HRAS protein]], Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [EGF protein promotes the reaction [EGFR protein binds to HRAS protein]]] CTD PMID:10807665 diarsenic trioxide increases expression ISO RGD:730881 6480464 Arsenic Trioxide results in increased expression of HRAS mRNA CTD PMID:29633893 diarsenic trioxide multiple interactions ISO RGD:730881 6480464 [Tetradecanoylphorbol Acetate co-treated with Arsenic Trioxide] results in increased expression of HRAS mRNA CTD PMID:18922899 dibenzoylmethane multiple interactions ISO RGD:730881 6480464 dibenzoylmethane inhibits the reaction [Estradiol results in increased expression of HRAS mRNA] CTD PMID:16051634 dichlorine multiple interactions EXP 6480464 [Ozone co-treated with Chlorine] results in decreased expression of HRAS mRNA CTD PMID:18636392 diclofenac affects expression ISO RGD:730881 6480464 Diclofenac affects the expression of HRAS mRNA CTD PMID:24752500 dimethyl sulfoxide affects expression ISO RGD:730881 6480464 Dimethyl Sulfoxide affects the expression of HRAS mRNA CTD PMID:24834073 dioxygen multiple interactions ISO RGD:730881 6480464 Oxygen deficiency inhibits the reaction [HRAS protein promotes the reaction [[sodium bichromate results in increased abundance of chromium hexavalent ion] which results in increased abundance of Hydroxyl Radical]] CTD PMID:14971653 doxifluridine decreases response to substance ISO RGD:730881 6480464 HRAS protein results in decreased susceptibility to doxifluridine CTD PMID:16734730 doxorubicin increases expression ISO RGD:730881 6480464 Doxorubicin results in increased expression of HRAS mRNA CTD PMID:16001973 , PMID:29803840 doxorubicin multiple interactions ISO RGD:730881 6480464 Doxorubicin inhibits the reaction [hydroquinone results in decreased expression of HRAS protein] CTD PMID:26047893 elemental selenium multiple interactions ISO RGD:730881 6480464 [Selenium co-treated with Vitamin E] results in increased expression of HRAS mRNA CTD PMID:19244175 elemental selenium increases expression ISO RGD:730881 6480464 Selenium results in increased expression of HRAS mRNA CTD PMID:19244175 ellagic acid multiple interactions ISO RGD:10730 6480464 [Ellagic Acid co-treated with Plant Extracts] inhibits the reaction [9 more ... CTD PMID:20103723 enzyme inhibitor multiple interactions ISO RGD:730881 6480464 [Enzyme Inhibitors binds to and results in decreased activity of SOS1 protein] inhibits the reaction [HRAS protein binds to Guanosine Triphosphate] more ... CTD PMID:25825487 epoxiconazole decreases expression ISO RGD:10730 6480464 epoxiconazole results in decreased expression of HRAS mRNA CTD PMID:35436446 erastin increases response to substance ISO RGD:730881 6480464 HRAS protein modified form results in increased susceptibility to erastin CTD PMID:17568748 ethanol affects splicing ISO RGD:10730 6480464 Ethanol affects the splicing of HRAS mRNA CTD PMID:30319688 ethanol increases expression ISO RGD:10730 6480464 Ethanol results in increased expression of HRAS mRNA CTD PMID:35149083 ethyl methanesulfonate increases expression ISO RGD:730881 6480464 Ethyl Methanesulfonate results in increased expression of HRAS mRNA CTD PMID:23649840 eugenol decreases expression ISO RGD:10730 6480464 Eugenol results in decreased expression of HRAS protein CTD PMID:20537511 farnesol multiple interactions ISO RGD:730881 6480464 Farnesol inhibits the reaction [Simvastatin results in decreased farnesylation of and affects the localization of HRAS protein] CTD PMID:12477733 farnesyl diphosphate multiple interactions ISO RGD:730881 6480464 farnesyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [Lipopolysaccharides results in increased activity of HRAS protein]], farnesyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [Lipopolysaccharides results in increased localization of HRAS protein]] CTD PMID:18625914 fenofibrate multiple interactions ISO RGD:10730 6480464 [Fenofibrate co-treated with Diethylnitrosamine] results in increased expression of HRAS mRNA CTD PMID:18978307 fenthion increases expression ISO RGD:10730 6480464 Fenthion results in increased expression of HRAS mRNA CTD PMID:34813904 finasteride increases expression EXP 6480464 Finasteride results in increased expression of HRAS mRNA CTD PMID:24136188 fipronil decreases expression EXP 6480464 fipronil results in decreased expression of HRAS mRNA CTD PMID:23962444 flurbiprofen multiple interactions ISO RGD:10730 6480464 HRAS protein affects the reaction [Flurbiprofen results in increased expression of PSCA mRNA] CTD PMID:16949054 flutamide increases expression EXP 6480464 Flutamide results in increased expression of HRAS mRNA CTD PMID:24136188 folic acid increases expression ISO RGD:10730 6480464 Folic Acid results in increased expression of HRAS mRNA CTD PMID:2566606 folic acid multiple interactions ISO RGD:10730 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of HRAS mRNA CTD PMID:22206623 formaldehyde increases expression ISO RGD:730881 6480464 Formaldehyde results in increased expression of HRAS mRNA CTD PMID:23649840 formaldehyde increases expression EXP 6480464 Formaldehyde results in increased expression of HRAS mRNA CTD PMID:9149109 GDP multiple interactions ISO RGD:730881 6480464 [Enzyme Inhibitors binds to and results in decreased activity of SOS1 protein] promotes the reaction [HRAS protein binds to Guanosine Diphosphate], Enzyme Inhibitors inhibits the reaction [SOS1 protein binds to [HRAS protein binds to Guanosine Diphosphate]] CTD PMID:25825487 geraniol multiple interactions ISO RGD:10730 6480464 [Tetradecanoylphorbol Acetate co-treated with 9 more ... CTD PMID:22760862 glafenine increases expression EXP 6480464 Glafenine results in increased expression of HRAS mRNA CTD PMID:24136188 gliotoxin multiple interactions ISO RGD:10730 6480464 Gliotoxin inhibits the reaction [Acetaminophen results in increased activity of HRAS protein] CTD PMID:19739265 glucaric acid multiple interactions ISO RGD:10730 6480464 [Glucaric Acid co-treated with Plant Extracts] inhibits the reaction [9 more ... CTD PMID:20103723 glucose increases activity EXP 6480464 Glucose results in increased activity of HRAS protein CTD PMID:16572112 glucose multiple interactions EXP 6480464 manumycin inhibits the reaction [Glucose results in increased activity of HRAS protein] CTD PMID:16572112 glutathione multiple interactions ISO RGD:730881 6480464 [Zinostatin co-treated with Glutathione] results in increased cleavage of HRAS gene, Dactinomycin promotes the reaction [[Zinostatin co-treated with Glutathione] results in increased cleavage of HRAS gene] CTD PMID:9345283 glycyrrhetinate decreases expression ISO RGD:730881 6480464 Glycyrrhetinic Acid results in decreased expression of HRAS protein CTD PMID:19958823 glycyrrhetinic acid decreases expression ISO RGD:730881 6480464 Glycyrrhetinic Acid results in decreased expression of HRAS protein CTD PMID:19958823 Goe 6976 multiple interactions ISO RGD:730881 6480464 Go 6976 inhibits the reaction [lead acetate results in increased activity of HRAS protein] CTD PMID:19133285 GTP multiple interactions ISO RGD:730881 6480464 [Enzyme Inhibitors binds to and results in decreased activity of SOS1 protein] inhibits the reaction [HRAS protein binds to Guanosine Triphosphate] CTD PMID:25825487 heptachlor decreases expression ISO RGD:730881 6480464 Heptachlor results in decreased expression of HRAS mRNA CTD PMID:1771636 hydrogen peroxide increases expression ISO RGD:730881 6480464 Hydrogen Peroxide results in increased expression of HRAS mRNA CTD PMID:11008122 hydrogen peroxide multiple interactions ISO RGD:10730 6480464 HRAS protein affects the susceptibility to [Hydrogen Peroxide results in increased activity of MAPK1 protein], HRAS protein affects the susceptibility to [Hydrogen Peroxide results in increased activity of MAPK3 protein] CTD PMID:14975446 hydroquinone multiple interactions ISO RGD:730881 6480464 3-aminobenzamide inhibits the reaction [hydroquinone results in increased expression of HRAS protein] more ... CTD PMID:26047893 hydroquinone affects expression ISO RGD:730881 6480464 hydroquinone affects the expression of HRAS mRNA, hydroquinone affects the expression of HRAS protein CTD PMID:26047893 hydroxyl multiple interactions ISO RGD:730881 6480464 HRAS protein promotes the reaction [[sodium bichromate results in increased abundance of chromium hexavalent ion] which results in increased abundance of Hydroxyl Radical], Oxygen deficiency inhibits the reaction [HRAS protein promotes the reaction [[sodium bichromate results in increased abundance of chromium hexavalent ion] which results in increased abundance of Hydroxyl Radical]] CTD PMID:14971653 iodoacetic acid increases response to substance ISO RGD:730881 6480464 HRAS protein modified form results in increased susceptibility to Iodoacetic Acid CTD PMID:19923925 iron atom multiple interactions EXP 6480464 HRAS protein affects the reaction [Iron results in increased phosphorylation of AKT1 protein] more ... CTD PMID:17172471 iron atom affects localization EXP 6480464 Iron affects the localization of HRAS protein CTD PMID:17172471 iron(0) multiple interactions EXP 6480464 HRAS protein affects the reaction [Iron results in increased phosphorylation of AKT1 protein] more ... CTD PMID:17172471 iron(0) affects localization EXP 6480464 Iron affects the localization of HRAS protein CTD PMID:17172471 iron(2+) sulfate (anhydrous) multiple interactions EXP 6480464 ferrous sulfate promotes the reaction [MAP3K7 protein binds to HRAS protein binds to PIK3R1 protein] more ... CTD PMID:17172471 iron(2+) sulfate (anhydrous) affects localization EXP 6480464 ferrous sulfate affects the localization of HRAS protein CTD PMID:17172471 isoprenaline increases activity EXP 6480464 Isoproterenol results in increased activity of HRAS protein CTD PMID:8484791 isoprene increases mutagenesis ISO RGD:10730 6480464 isoprene results in increased mutagenesis of HRAS gene CTD PMID:11397402 , PMID:9111215 ketamine multiple interactions ISO RGD:10730 6480464 Ketamine inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased activity of HRAS protein] CTD PMID:19540866 lead diacetate multiple interactions EXP 6480464 lead acetate inhibits the reaction [HSPA5 protein binds to HRAS enhancer] CTD PMID:15111246 lead diacetate increases activity ISO RGD:730881 6480464 lead acetate results in increased activity of HRAS protein CTD PMID:19133285 lead diacetate multiple interactions ISO RGD:730881 6480464 4-((3-bromophenyl)amino)-6 more ... CTD PMID:19133285 lead(0) multiple interactions EXP 6480464 Lead inhibits the reaction [HSPA5 protein binds to HRAS enhancer] CTD PMID:15111246 lead(0) affects splicing ISO RGD:730881 6480464 Lead affects the splicing of HRAS mRNA CTD PMID:28903495 lead(2+) multiple interactions EXP 6480464 Lead inhibits the reaction [HSPA5 protein binds to HRAS enhancer] CTD PMID:15111246 lead(2+) affects splicing ISO RGD:730881 6480464 Lead affects the splicing of HRAS mRNA CTD PMID:28903495 limonene multiple interactions ISO RGD:730881 6480464 limonene inhibits the reaction [HRAS protein results in increased susceptibility to Methylnitrosourea] CTD PMID:11802805 lipopolysaccharide increases localization ISO RGD:730881 6480464 Lipopolysaccharides results in increased localization of HRAS protein CTD PMID:18625914 lipopolysaccharide increases expression ISO RGD:730881 6480464 Lipopolysaccharides results in increased expression of HRAS mRNA CTD PMID:35953652 lipopolysaccharide increases activity ISO RGD:730881 6480464 Lipopolysaccharides results in increased activity of HRAS protein CTD PMID:18625914 lipopolysaccharide multiple interactions ISO RGD:730881 6480464 farnesyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [Lipopolysaccharides results in increased activity of HRAS protein]] more ... CTD PMID:18625914 lipopolysaccharide multiple interactions ISO RGD:10730 6480464 Ketamine inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased activity of HRAS protein] more ... CTD PMID:19540866 lipopolysaccharide increases prenylation ISO RGD:730881 6480464 Lipopolysaccharides results in increased prenylation of HRAS protein CTD PMID:18625914 lonafarnib multiple interactions ISO RGD:730881 6480464 lonafarnib inhibits the reaction [TNF protein results in increased activity of HRAS protein] CTD PMID:15090542 lovastatin decreases prenylation ISO RGD:730881 6480464 Lovastatin results in decreased prenylation of HRAS protein CTD PMID:16156861 lovastatin multiple interactions ISO RGD:730881 6480464 Lovastatin results in decreased prenylation of and results in decreased localization of HRAS protein CTD PMID:19360310 LY294002 multiple interactions ISO RGD:730881 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [HRAS protein inhibits the reaction [1 more ... CTD PMID:18829283 more ... LY294002 multiple interactions ISO RGD:10730 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[Tunicamycin co-treated with HRAS protein] results in increased expression of PCNA protein] more ... CTD PMID:24898257 malathion multiple interactions ISO RGD:730881 6480464 [Malathion co-treated with Estrogens] results in increased expression of HRAS mRNA CTD PMID:18204794 malathion increases expression ISO RGD:730881 6480464 Malathion results in increased expression of HRAS mRNA, Malathion results in increased expression of HRAS protein CTD PMID:18204794 , PMID:19787260 manumycin A multiple interactions ISO RGD:10730 6480464 manumycin inhibits the reaction [Acetaminophen results in increased activity of HRAS protein] CTD PMID:19739265 manumycin A multiple interactions EXP 6480464 manumycin inhibits the reaction [Glucose results in increased activity of HRAS protein], manumycin inhibits the reaction [INS1 protein results in increased farnesylation of HRAS protein] CTD PMID:16572112 , PMID:19002579 manumycin A decreases expression ISO RGD:730881 6480464 manumycin results in decreased expression of HRAS protein CTD PMID:19958823 MeIQ increases mutagenesis ISO RGD:10730 6480464 2-amino-3 more ... CTD PMID:1540938 , PMID:8844820 MeIQ increases activity ISO RGD:10730 6480464 2-amino-3 more ... CTD PMID:1540938 MeIQx increases mutagenesis EXP 6480464 2-amino-3 more ... CTD PMID:2009133 mercury atom multiple interactions EXP 6480464 Mercury promotes the reaction [HSPA5 protein binds to HRAS enhancer] CTD PMID:15111246 mercury dichloride multiple interactions EXP 6480464 Mercuric Chloride promotes the reaction [HSPA5 protein binds to HRAS enhancer] CTD PMID:15111246 mercury(0) multiple interactions EXP 6480464 Mercury promotes the reaction [HSPA5 protein binds to HRAS enhancer] CTD PMID:15111246 metformin multiple interactions ISO RGD:730881 6480464 [Paclitaxel co-treated with Metformin] results in decreased expression of HRAS mRNA CTD PMID:29309887 methamphetamine decreases expression EXP 6480464 Methamphetamine results in decreased expression of HRAS mRNA CTD PMID:15644446 methapyrilene increases expression EXP 6480464 Methapyrilene results in increased expression of HRAS mRNA CTD PMID:30467583 methoxychlor increases methylation EXP 6480464 Methoxychlor results in increased methylation of HRAS gene CTD PMID:23303685 methoxychlor decreases expression EXP 6480464 Methoxychlor results in decreased expression of HRAS mRNA CTD PMID:23303685 methyl methanesulfonate increases expression ISO RGD:730881 6480464 Methyl Methanesulfonate results in increased expression of HRAS mRNA CTD PMID:23649840 methylglyoxal increases activity EXP 6480464 Pyruvaldehyde results in increased activity of HRAS protein CTD PMID:17635749 Mezerein multiple interactions ISO RGD:10730 6480464 [9 more ... CTD PMID:3115617 mifepristone multiple interactions ISO RGD:730881 6480464 Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [EGF protein promotes the reaction [EGFR protein binds to HRAS protein]]] CTD PMID:10807665 monosodium L-glutamate decreases expression EXP 6480464 Sodium Glutamate results in decreased expression of HRAS mRNA CTD PMID:28954212 myricetin decreases activity ISO RGD:10730 6480464 myricetin results in decreased activity of HRAS protein CTD PMID:17693661 N-acetyl-L-cysteine multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [Nitrofurazone results in increased expression of HRAS mRNA] CTD PMID:15945272 N-acetyl-L-cysteine multiple interactions ISO RGD:730881 6480464 Acetylcysteine inhibits the reaction [HRAS protein mutant form results in increased susceptibility to sodium arsenite] CTD PMID:25199681 N-ethyl-N-nitrosourea increases response to substance ISO RGD:730881 6480464 HRAS protein results in increased susceptibility to Ethylnitrosourea CTD PMID:11182032 N-ethyl-N-nitrosourea increases response to substance ISO RGD:10730 6480464 HRAS protein results in increased susceptibility to Ethylnitrosourea CTD PMID:26558449 N-hydroxy-4-aminobiphenyl multiple interactions ISO RGD:730881 6480464 [N-hydroxy-4-aminobiphenyl co-treated with Copper] results in increased mutagenesis of HRAS gene CTD PMID:11275476 N-methyl-N'-nitro-N-nitrosoguanidine multiple interactions ISO RGD:730881 6480464 Methylnitronitrosoguanidine inhibits the reaction [EGF protein results in increased activity of HRAS protein] CTD PMID:15708576 N-methyl-N-nitrosourea multiple interactions ISO RGD:730881 6480464 limonene inhibits the reaction [HRAS protein results in increased susceptibility to Methylnitrosourea] CTD PMID:11802805 N-methyl-N-nitrosourea increases response to substance ISO RGD:10730 6480464 HRAS protein results in increased susceptibility to Methylnitrosourea CTD PMID:28421967 N-methyl-N-nitrosourea increases response to substance ISO RGD:730881 6480464 HRAS protein results in increased susceptibility to Methylnitrosourea CTD PMID:11182032 more ... N-methyl-N-nitrosourea increases mutagenesis EXP 6480464 Methylnitrosourea results in increased mutagenesis of HRAS gene CTD PMID:10767621 , PMID:15688392 N-methyl-N-nitrosourea decreases response to substance EXP 6480464 HRAS protein results in decreased susceptibility to Methylnitrosourea CTD PMID:11973638 N-nitrosodiethylamine multiple interactions ISO RGD:10730 6480464 [Diethylnitrosamine co-treated with HRAS protein] results in increased activity of GOT1 protein more ... CTD PMID:12499697 , PMID:18978307 N-nitrosodiethylamine increases expression ISO RGD:10730 6480464 Diethylnitrosamine results in increased expression of HRAS mRNA CTD PMID:26464624 N-nitrosodiethylamine increases mutagenesis ISO RGD:10730 6480464 Diethylnitrosamine results in increased mutagenesis of HRAS gene CTD PMID:15592514 more ... N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of HRAS mRNA CTD PMID:7910516 NAD zwitterion multiple interactions ISO RGD:730881 6480464 [2-phenylphenol metabolite co-treated with NAD co-treated with Copper] results in increased mutagenesis of HRAS gene more ... CTD PMID:10334203 NAD(+) multiple interactions ISO RGD:730881 6480464 [2-phenylphenol metabolite co-treated with NAD co-treated with Copper] results in increased mutagenesis of HRAS gene more ... CTD PMID:10334203 naringin multiple interactions EXP 6480464 HRAS protein affects the reaction [naringin results in decreased expression of CDK2 protein] more ... CTD PMID:18951945 naringin multiple interactions ISO RGD:730881 6480464 HRAS protein affects the reaction [naringin results in decreased expression of CDK2 protein] more ... CTD PMID:18296682 naringin increases activity ISO RGD:730881 6480464 naringin results in increased activity of HRAS protein CTD PMID:18296682 naringin increases activity EXP 6480464 naringin results in increased activity of HRAS protein CTD PMID:18951945 nicotine multiple interactions ISO RGD:10730 6480464 [Nicotine co-treated with 1-Methyl-4-phenyl-1 more ... CTD PMID:20230807 nicotine increases activity EXP 6480464 Nicotine results in increased activity of HRAS protein CTD PMID:15983034 nimesulide multiple interactions ISO RGD:730881 6480464 nimesulide inhibits the reaction [[4-Nitroquinoline-1-oxide co-treated with HRAS] results in increased expression of CCND1 mRNA], nimesulide inhibits the reaction [[4-Nitroquinoline-1-oxide co-treated with HRAS] results in increased expression of PTGS2 mRNA] CTD PMID:20043093 nitrofurazone increases expression EXP 6480464 Nitrofurazone results in increased expression of HRAS mRNA CTD PMID:15945272 nitrofurazone multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [Nitrofurazone results in increased expression of HRAS mRNA] CTD PMID:15945272 obeticholic acid decreases expression ISO RGD:730881 6480464 obeticholic acid results in decreased expression of HRAS mRNA CTD PMID:27939613 ochratoxin A increases expression EXP 6480464 ochratoxin A results in increased expression of HRAS mRNA CTD PMID:23358140 ozone multiple interactions EXP 6480464 [Ozone co-treated with Chlorine] results in decreased expression of HRAS mRNA CTD PMID:18636392 ozone multiple interactions ISO RGD:10730 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of HRAS mRNA CTD PMID:34911549 ozone multiple interactions ISO RGD:730881 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of HRAS mRNA more ... CTD PMID:32699268 paclitaxel multiple interactions ISO RGD:730881 6480464 [Paclitaxel co-treated with Metformin] results in decreased expression of HRAS mRNA CTD PMID:29309887 paracetamol affects expression ISO RGD:10730 6480464 Acetaminophen affects the expression of HRAS mRNA CTD PMID:17562736 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of HRAS mRNA CTD PMID:33387578 paracetamol multiple interactions ISO RGD:10730 6480464 Gliotoxin inhibits the reaction [Acetaminophen results in increased activity of HRAS protein], manumycin inhibits the reaction [Acetaminophen results in increased activity of HRAS protein] CTD PMID:19739265 paracetamol increases activity ISO RGD:10730 6480464 Acetaminophen results in increased activity of HRAS protein CTD PMID:19739265 paraquat affects splicing ISO RGD:730881 6480464 Paraquat affects the splicing of HRAS mRNA CTD PMID:23613995 parathion multiple interactions ISO RGD:730881 6480464 [Parathion co-treated with Estrogens] results in increased expression of HRAS mRNA CTD PMID:18204794 parathion increases expression ISO RGD:730881 6480464 Parathion results in increased expression of HRAS protein CTD PMID:19787260 perfluorononanoic acid decreases expression ISO RGD:730881 6480464 perfluoro-n-nonanoic acid results in decreased expression of HRAS mRNA CTD PMID:25812627 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:730881 6480464 perfluorooctane sulfonic acid results in decreased expression of HRAS mRNA CTD PMID:25812627 perfluorooctanoic acid decreases expression ISO RGD:730881 6480464 perfluorooctanoic acid results in decreased expression of HRAS mRNA CTD PMID:25812627 phenobarbital decreases mutagenesis ISO RGD:10730 6480464 Phenobarbital results in decreased mutagenesis of HRAS protein CTD PMID:11753661 PhIP increases expression ISO RGD:730881 6480464 2-amino-1-methyl-6-phenylimidazo(4 more ... CTD PMID:22307971 PhIP increases mutagenesis EXP 6480464 2-amino-1-methyl-6-phenylimidazo(4, 5-b)pyridine results in increased mutagenesis of HRAS gene CTD PMID:11165753 , PMID:9433479 PhIP affects response to substance ISO RGD:730881 6480464 HRAS protein affects the susceptibility to 2-amino-1-methyl-6-phenylimidazo(4, 5-b)pyridine CTD PMID:22307971 PhIP multiple interactions ISO RGD:730881 6480464 HRAS protein affects the reaction [2-amino-1-methyl-6-phenylimidazo(4 more ... CTD PMID:22307971 PhIP multiple interactions EXP 6480464 2-amino-1-methyl-6-phenylimidazo(4 more ... CTD PMID:12507937 more ... PhIP increases mutagenesis ISO RGD:730881 6480464 2-amino-1-methyl-6-phenylimidazo(4, 5-b)pyridine results in increased mutagenesis of HRAS gene CTD PMID:15132766 phlorizin increases expression ISO RGD:10730 6480464 Phlorhizin results in increased expression of HRAS mRNA CTD PMID:22538082 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:730881 6480464 [Tetradecanoylphorbol Acetate co-treated with arsenic trioxide] results in increased expression of HRAS mRNA, HRAS protein affects the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of CDH5 protein] CTD PMID:18922899 , PMID:24211779 phorbol 13-acetate 12-myristate increases expression ISO RGD:10730 6480464 Tetradecanoylphorbol Acetate results in increased expression of HRAS mRNA CTD PMID:17106253 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:10730 6480464 [9 more ... CTD PMID:11241758 more ... plutonium atom increases mutagenesis EXP 6480464 Plutonium results in increased mutagenesis of HRAS gene CTD PMID:9255578 progesterone increases expression ISO RGD:10730 6480464 Progesterone results in increased expression of HRAS mRNA CTD PMID:21549006 quercetin decreases expression ISO RGD:730881 6480464 Quercetin results in decreased expression of HRAS mRNA, Quercetin results in decreased expression of HRAS protein CTD PMID:10652438 quercetin increases expression ISO RGD:730881 6480464 Quercetin results in increased expression of HRAS mRNA CTD PMID:21632981 reactive oxygen species multiple interactions ISO RGD:10730 6480464 PRDX1 protein inhibits the reaction [HRAS protein mutant form results in increased abundance of Reactive Oxygen Species] CTD PMID:27517622 reactive oxygen species affects abundance ISO RGD:730881 6480464 HRAS protein affects the abundance of Reactive Oxygen Species CTD PMID:22307971 reactive oxygen species multiple interactions ISO RGD:730881 6480464 HRAS protein affects the reaction [2-amino-1-methyl-6-phenylimidazo(4, 5-b)pyridine results in increased abundance of Reactive Oxygen Species] CTD PMID:22307971 reactive oxygen species increases abundance ISO RGD:10730 6480464 HRAS protein mutant form results in increased abundance of Reactive Oxygen Species CTD PMID:27517622 resveratrol affects expression ISO RGD:730881 6480464 resveratrol affects the expression of HRAS mRNA mutant form, resveratrol affects the expression of HRAS protein mutant form CTD PMID:16369916 resveratrol multiple interactions ISO RGD:10730 6480464 [Ellagic Acid co-treated with resveratrol] inhibits the reaction [9 more ... CTD PMID:20103723 resveratrol multiple interactions ISO RGD:730881 6480464 HRAS protein promotes the reaction [resveratrol results in increased activity of MAPK1 protein] more ... CTD PMID:11889192 Risedronate sodium decreases prenylation ISO RGD:10730 6480464 Risedronic Acid results in decreased prenylation of HRAS protein CTD PMID:9556058 rotenone decreases expression ISO RGD:10730 6480464 Rotenone results in decreased expression of HRAS mRNA CTD PMID:10630619 selenium atom multiple interactions ISO RGD:730881 6480464 [Selenium co-treated with Vitamin E] results in increased expression of HRAS mRNA CTD PMID:19244175 selenium atom increases expression ISO RGD:730881 6480464 Selenium results in increased expression of HRAS mRNA CTD PMID:19244175 serpentine asbestos increases expression ISO RGD:730881 6480464 Asbestos, Serpentine results in increased expression of HRAS protein CTD PMID:10905503 serpentine asbestos multiple interactions ISO RGD:730881 6480464 tobacco tar promotes the reaction [Asbestos, Serpentine results in increased expression of HRAS protein] CTD PMID:10905503 sevoflurane increases expression ISO RGD:730881 6480464 Sevoflurane results in increased expression of HRAS mRNA CTD PMID:35953652 silicon dioxide increases expression ISO RGD:730881 6480464 Silicon Dioxide analog results in increased expression of HRAS mRNA CTD PMID:25895662 simvastatin multiple interactions ISO RGD:730881 6480464 Farnesol inhibits the reaction [Simvastatin results in decreased farnesylation of and affects the localization of HRAS protein] more ... CTD PMID:12477733 more ... simvastatin decreases activity ISO RGD:10730 6480464 Simvastatin results in decreased activity of HRAS CTD PMID:11914545 sirolimus multiple interactions ISO RGD:10730 6480464 [Sirolimus co-treated with HRAS protein] results in decreased expression of ERN1 protein more ... CTD PMID:24898257 sirolimus multiple interactions ISO RGD:730881 6480464 Sirolimus inhibits the reaction [HRAS protein mutant form results in increased expression of MIR146A mRNA] more ... CTD PMID:30619488 sodium arsenite multiple interactions ISO RGD:730881 6480464 Acetylcysteine inhibits the reaction [HRAS protein mutant form results in increased susceptibility to sodium arsenite], sodium arsenite inhibits the reaction [HRAS protein mutant form results in increased activity of CAT protein] CTD PMID:25199681 sodium arsenite increases expression ISO RGD:10730 6480464 sodium arsenite results in increased expression of HRAS mRNA CTD PMID:14691202 , PMID:35364107 sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of HRAS mRNA CTD PMID:11241755 , PMID:16876216 sodium arsenite decreases expression ISO RGD:10730 6480464 sodium arsenite results in decreased expression of HRAS mRNA CTD PMID:19822182 sodium arsenite decreases methylation ISO RGD:10730 6480464 sodium arsenite results in decreased methylation of HRAS promoter CTD PMID:12016150 sodium arsenite increases response to substance ISO RGD:10730 6480464 HRAS gene mutant form results in increased susceptibility to sodium arsenite CTD PMID:22700541 sodium arsenite increases response to substance ISO RGD:730881 6480464 HRAS protein mutant form results in increased susceptibility to sodium arsenite CTD PMID:25199681 sodium arsenite increases expression ISO RGD:730881 6480464 sodium arsenite results in increased expression of HRAS mRNA, sodium arsenite results in increased expression of HRAS protein CTD PMID:16039940 , PMID:19464579 sodium dichromate multiple interactions ISO RGD:730881 6480464 HRAS protein promotes the reaction [[sodium bichromate results in increased abundance of chromium hexavalent ion] which results in increased abundance of Hydroxyl Radical] more ... CTD PMID:14971653 streptozocin decreases farnesylation EXP 6480464 Streptozocin results in decreased farnesylation of HRAS protein CTD PMID:19002579 SU6656 multiple interactions ISO RGD:730881 6480464 SU 6656 inhibits the reaction [lead acetate results in increased activity of HRAS protein] CTD PMID:19133285 sulfur dioxide multiple interactions EXP 6480464 [Sulfur Dioxide co-treated with Benzo(a)pyrene] results in increased expression of HRAS mRNA more ... CTD PMID:19408242 , PMID:20064080 sulfur dioxide increases expression EXP 6480464 Sulfur Dioxide results in increased expression of HRAS mRNA, Sulfur Dioxide results in increased expression of HRAS protein CTD PMID:19408242 , PMID:20064080 superoxide increases abundance ISO RGD:730881 6480464 HRAS protein mutant form results in increased abundance of Superoxides CTD PMID:11313892 superoxide multiple interactions ISO RGD:730881 6480464 [HRAS protein mutant form results in increased abundance of Superoxides] which results in decreased susceptibility to TNF protein CTD PMID:11313892 testosterone decreases expression ISO RGD:10730 6480464 Testosterone results in decreased expression of HRAS mRNA CTD PMID:20403060 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of HRAS mRNA CTD PMID:8847708 Tetranitromethane increases mutagenesis EXP 6480464 Tetranitromethane results in increased mutagenesis of HRAS gene CTD PMID:9255578 thapsigargin multiple interactions ISO RGD:10730 6480464 [Thapsigargin co-treated with HRAS protein] results in decreased phosphorylation of MAPK1 protein more ... CTD PMID:24898257 theaflavin multiple interactions ISO RGD:10730 6480464 theaflavin inhibits the reaction [Benzo(a)pyrene results in increased expression of HRAS mRNA], theaflavin inhibits the reaction [Benzo(a)pyrene results in increased expression of HRAS protein] CTD PMID:18656336 tipifarnib decreases metabolic processing ISO RGD:730881 6480464 tipifarnib results in decreased metabolism of HRAS protein CTD PMID:15728126 tipifarnib increases response to substance EXP 6480464 HRAS gene mutant form results in increased susceptibility to tipifarnib CTD PMID:16403772 , PMID:16648579 toluene affects expression EXP 6480464 Toluene affects the expression of HRAS mRNA CTD PMID:21827849 triciribine multiple interactions ISO RGD:730881 6480464 triciribine inhibits the reaction [HRAS protein results in increased activity of MMP2 protein] CTD PMID:23877152 trimethyltin increases expression ISO RGD:10730 6480464 trimethyltin results in increased expression of HRAS mRNA CTD PMID:21435392 Triptolide decreases expression EXP 6480464 triptolide results in decreased expression of HRAS mRNA CTD PMID:23639586 troglitazone increases expression ISO RGD:10730 6480464 troglitazone results in increased expression of HRAS mRNA CTD PMID:17569031 troglitazone multiple interactions ISO RGD:10730 6480464 troglitazone promotes the reaction [HRAS protein results in increased susceptibility to Urethane] CTD PMID:26558449 tunicamycin multiple interactions ISO RGD:10730 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[Tunicamycin co-treated with HRAS protein] results in increased expression of PCNA protein] more ... CTD PMID:24898257 urethane multiple interactions ISO RGD:730881 6480464 HRAS protein promotes the reaction [Urethane results in increased expression of CCND1 protein] CTD PMID:11307925 urethane increases response to substance ISO RGD:10730 6480464 HRAS protein results in increased susceptibility to Urethane CTD PMID:15902970 , PMID:26558449 urethane increases expression ISO RGD:10730 6480464 Urethane results in increased expression of HRAS mRNA CTD PMID:18465119 urethane multiple interactions ISO RGD:10730 6480464 HRAS protein promotes the reaction [Urethane results in increased expression of AURKB mRNA] more ... CTD PMID:11062179 , PMID:26558449 urethane increases mutagenesis ISO RGD:730881 6480464 Urethane results in increased mutagenesis of HRAS gene CTD PMID:10779650 , PMID:12765245 urethane increases response to substance ISO RGD:730881 6480464 HRAS protein results in increased susceptibility to Urethane CTD PMID:10779650 , PMID:11552296 ursodeoxycholic acid multiple interactions EXP 6480464 Ursodeoxycholic Acid inhibits the reaction [Azoxymethane results in increased activity of HRAS protein] CTD PMID:12839936 valproic acid increases methylation ISO RGD:730881 6480464 Valproic Acid results in increased methylation of HRAS gene CTD PMID:29154799 valproic acid affects expression ISO RGD:730881 6480464 Valproic Acid affects the expression of HRAS mRNA CTD PMID:25979313 valproic acid increases expression ISO RGD:730881 6480464 Valproic Acid results in increased expression of HRAS mRNA CTD PMID:23179753 vincristine increases expression ISO RGD:730881 6480464 Vincristine results in increased expression of HRAS mRNA CTD PMID:16001973 vinyl carbamate increases mutagenesis ISO RGD:730881 6480464 vinyl carbamate results in increased mutagenesis of HRAS gene CTD PMID:12765245 vitamin E multiple interactions ISO RGD:10730 6480464 Vitamin E inhibits the reaction [Urethane promotes the reaction [RAF1 protein binds to HRAS protein]] CTD PMID:11062179 vitamin E increases expression ISO RGD:730881 6480464 Vitamin E results in increased expression of HRAS mRNA CTD PMID:19244175 vitamin E multiple interactions ISO RGD:730881 6480464 [Selenium co-treated with Vitamin E] results in increased expression of HRAS mRNA CTD PMID:19244175 zearalenone decreases expression ISO RGD:10730 6480464 Zearalenone results in decreased expression of HRAS mRNA CTD PMID:30717214 zidovudine multiple interactions ISO RGD:10730 6480464 [Zidovudine co-treated with Tetradecanoylphorbol Acetate] results in increased mutagenesis of HRAS gene CTD PMID:9766437 zoledronic acid decreases localization ISO RGD:730881 6480464 zoledronic acid results in decreased localization of HRAS protein CTD PMID:11986784 zoledronic acid increases expression ISO RGD:730881 6480464 zoledronic acid results in increased expression of HRAS protein CTD PMID:28871336
